Injectable liquid formulation of paracetamol

Details Injectable liquid formulation of paracetamol Injectable liquid formulation of paracetamol

2004-02-16

2011-12-06

Duffy, Patricia A (Department: 1612)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C424S400000, C514S516000, C514S731000, C514S970000, C564S007000

Reexamination Certificate

active

08071619

ABSTRACT:
The invention relates to a novel injectable liquid formulation of paracetamol, comprising an aqueous solvent, a buffer agent with a pKa between 4.5 and 6.5, an isotonic agent and the dimer of paracetamol of formula (I), a method for preparation of said formulation and the use of said dimer for the stabilisation of a liquid paracetamol pharmaceutical formulation.

REFERENCES:
patent: 4794117 (1988-12-01), Corbiere
patent: 6028222 (2000-02-01), Dietlin et al.
patent: 6992218 (2006-01-01), Dietlin et al.
patent: 2004/0054012 (2004-03-01), Dietlin et al.
patent: 2004/0247627 (2004-12-01), Nguyen-Xuan
patent: 85/04106 (1985-09-01), None
patent: 98/05314 (1998-02-01), None
patent: 00/07588 (2000-02-01), None
patent: 01/93830 (2001-12-01), None
patent: WO 02/072080 (2002-09-01), None
patent: WO 03/033026 (2003-04-01), None
Lambert et al., Organic Structural Spectroscopy. Upper Saddle River, NJ: Prentice-Hall, Inc., 1998.
D. W. Potter et al.; “Identification of Acetaminophen Polymerization Products Catalyzed by Horseradish Peroxidase”, The Journal of Biological Chemistry, vol. 260, No. 22, Oct. 5, 1985, pp. 12174-12180. (Cited in the int'l. search report).
R. P. Mason et al.; “Free Radicals of Acetaminophen: Their Subsequent Reactions and Toxicological Significance”, Federation Proceedings, vol. 45, No. 10, Sep. 1986, pp. 2493-2499. (Cited in the int'l. search report).
William Clegg et al.; “An Oxidatively Coupled Dimer of Paracetamol”, Acta Crystallographica, Secion C., Crystal Structure Communications, 1998, C54 (12), pp. 1881-1882. (Cited in the int'l. search report).
Roberto Andreozzi et al., Paracetamol oxidation from aqueous solutions by means of ozonation and H2O2/UV system,Water Research37 (2003) 993-1004, Elsevier Science Ltd.
Potter et al., “Reactions of N-Acetyl-p-benzoquinone Imine with Reduced Glutathione, Acetaminophen, and NADPH,” Molecular Pharmacology 30:33-41 (1986) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Vilchez et al., “Spectrofluorimetric Determination of Paracetamol in Pharmaceuticals and Biological Fluids,” J. Parm. Biomed. Anal., 13 :119-1125 (1995) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
“Dissociation Constants of Inorganic Acids in Aqueous Solutions,” in Handbook of Chemistry and Physics, 65th Ed., CRC Press, Boca Raton, FL, p. D167 (1984) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
“Acetaminophen,” in the Merck Index, 12th Ed., Merck & Co., Inc., Whitehouse Station, NJ , p. 47 (1996) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (Ep Appl. No. 04711333)).
Fairbrother, Analytical Processes of Drug Substances, 3:1-109 (1974) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Koshy et al., “Stability of Aqueous Solutions of N-Acetyl-p-Aminophenol,” J. Of Pharmaceutical Sciences, 50 (2):113-118 (1961) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
“Protonic Equilibrium,” in Mahler et al., Biological Chemistry, 2nd Ed. 1971, Harper & Row, New York, NY, pp. 13-15 (1971) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)) .
Buffer capacity, inonic strength, and tables of pKa, pp. 8-9, http://analytical.biochem.purdue.edu/˜courses/undrgrad/221/wwwboard/handouts/index.html (downloaded Jan. 18, 2011) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
“General Preparative Procedures,” in Methods in Enzymology, vol. I, Academic Press Inc., New York, NY, pp. 138-146 (1955) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Swedish SmPC Perfalgan, http://www.lakemedelsverket.se/SPC—PIL/Pdf/humspc/Perfalgan%20solution%20for%20infusion@20.doc (downloaded Jan. 19, 2011) (no English translation—corresponds to UK SPC Perfalgan (Non Pat Lit #16), cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333) (alleged evidence of approval date of Perfalgan in Sweden on Feb. 8, 2002).
Nematollahi et al., “Electrochemical Oxidation of Acetaminophen in Aqueous Solutions: Kinetic Evaluation of Hydrolysis, Hydroxylation and Dimerization Processes,” Electrochimica Acta, 54:7407-7415 (2009) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Record from Newport database for injectable paracetamol (undated) (no English translation, cited in opposition.To counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333) (alleged evidence of launch date of Perfalgan in Sweden on Feb. 28, 2002).
Excerpt from Chapter 84 “Sterilization,” in Remington: Practice of, 19th Ed. 1995, Mack Publishing Co., Easton, Penn., p. 1463 (1995) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Report of Analyses Carried Out by the Central Analysis Service of the University of the Basque Country (Spain) on 1592414B1 (EP Appl. No. 04711333)).
Fischer et al., “Free-Radical Metabolites of Acetaminophen and a Dimethylated Derivative,” Environmental Health Perspectives, 64, 127-137 (1985) (in English, cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
UK SPC Perfalgan, http://emc.medicines.org.uk/printfriendlydocumentaspx?documentid=142888,compa . . . (downloaded 16 Jul. 2009) (in English, corres to Swedish SmPC Perfalgan (Non Pat Lit #10) cited in opposition to counterpart EP Pat. No. 1592414B1 (EP Appl. No. 04711333)).
Koshy et al., Stability of Aqueous Solutions of N-Acetyl-p-aminophenol, J. Pharma. Sciences, pp. 113-118 (1960).
Alves et al. Density Functional Theory Study of Metabolic Derivatives of the Oxidation of Paracetamol, Int'l J. of Quantum Chemistry, vol. 106, pp. 2617-2623 (2006).

Affiliated with

Also associated with

Rating

Injectable liquid formulation of paracetamol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable liquid formulation of paracetamol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable liquid formulation of paracetamol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4268249